Ciraparantag

Drug Profile

Ciraparantag

Alternative Names: Aripazine; PER 977

Latest Information Update: 10 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Perosphere
  • Class Amides; Coagulants; Piperazines; Small molecules
  • Mechanism of Action Blood coagulation factor modulators; Factor Xa inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Haemorrhage

Most Recent Events

  • 10 Sep 2017 Perosphere initiates enrolment in a phase I trial in Healthy volunteers in USA (NCT03288454)
  • 08 May 2017 Perosphere initiates enrolment in a phase II trial for Haemorrhage (In adults, In the elderly, In volunteers) in USA (NCT03172910)
  • 15 Dec 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top